BUBS AUSTRALIA LIMITED (BUB)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BUB - BUBS AUSTRALIA LIMITED

FNArena Sector : Dairy
Year End: June
GICS Industry Group : Food, Beverage & Tobacco
Debt/EBITDA: -0.38
Index:

Bubs is an Australian producer of infant formula and organic baby food and cereals. First listed in 1993, the company relisted in 2017 under the name Bubs Australia.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.115

22 Nov
2024

0.000

OPEN

$0.12

0.000

HIGH

$0.12

1,116,051

LOW

$0.12

TARGET
$0.138 19.6% upside
OTHER COMPANIES IN THE SAME SECTOR
A2M . BFC . BGA . FSF . NUC . NUC . SM1 . TFL .
FNARENA'S MARKET CONSENSUS FORECASTS
BUB: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx - 2.5 - 0.2 xxx
DPS (cps) xxx N/A 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-2.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx79.7 M
Book Value Per Share xxxxxxxxxxxxxxx4.1
Net Operating Cash Flow xxxxxxxxxxxxxxx-26.3 M
Net Profit Margin xxxxxxxxxxxxxxx-26.33 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-53.44 %
Return on Invested Capital xxxxxxxxxxxxxxx-51.66 %
Return on Assets xxxxxxxxxxxxxxx-31.72 %
Return on Equity xxxxxxxxxxxxxxx-53.44 %
Return on Total Capital xxxxxxxxxxxxxxx-43.58 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-26.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx6 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx7 M
Goodwill - Gross xxxxxxxxxxxxxxx91 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx18 M
Price To Book Value xxxxxxxxxxxxxxx3.15

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx0.24 %
Cost of Goods Sold xxxxxxxxxxxxxxx42 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx57 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

3

xxxxxxxxxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

30/08/2024

3

Neutral

$0.13

13.04%

Bubs Australia's FY24 result came in under Citi's expectations with EBITDA -$19.7m versus -$7.9m expected. The company also lowered expectations of better profitability with FY25 EBITDA guidance of $0.2m versus Citi's forecast of $3m.

The broker does think there are encouraging signs for the company given FDA approval in the US is expected in October 2025, in addition to positive expectations for the China segment.

Neutral/High Risk rating retained as Citi likes to wait for further signs a recovery is underway. Target price has gained 1c to 13c.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

BUB STOCK CHART

FNArena News on BUB

1
FNArena Corporate Results Monitor – 06-09-2024

Sep 06 2024 - Australia
2
Next Week At A Glance – 26-30 – Aug 2024

Aug 23 2024 - Weekly Reports
3
FNArena Corporate Results Monitor – 27-02-2024

Feb 27 2024 - Australia
4
FNArena Corporate Results Monitor – 01-09-2023

Sep 01 2023 - Australia
5
Rudi’s View: Bull, Bear & Bubble; AI Is The New Kingmaker

Jun 07 2023 - Rudi's View

Latest Dairy News

1
Buy Call For a2 Milk

Mar 21 2024 - Technicals
2
A2 Milking It

Feb 21 2024 - Australia
3
Treasure Chest: Bega Cheese

Oct 18 2022 - Treasure Chest
4
a2 Milk Pumps Up Growth Expectations

Oct 29 2021 - Australia
5
Bega Cheese: Melting Up?

Jun 01 2021 - Technicals
6
Synlait Milk Eyes Recovery, But Risks Remain

May 26 2021 - Australia
7
A2 Milk At A Crossroad In China?

Apr 22 2021 - Australia
8
Sales Slowdown Hits a2 Milk Guidance

Dec 21 2020 - Australia
9
Uncertainty Prevails For Synlait Milk

Sep 30 2020 - Small Caps
10
Daigou Drought Sours a2 Milk Outlook

Sep 29 2020 - Australia